Scientific Seminars - Course Library

Visit Scientific Seminars E-Platform

LOGIN OR REGISTER

COURSES

ALL

Defining the therapeutic algorithm in patients with HR positive breast cancer - France

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

Oncology

CREDITS

0.50 AMA PRA Category 1 Credit(s)™

Antibody Drug Conjugates (ADC) - France

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

Oncology

CREDITS

0.50 AMA PRA Category 1 Credit(s)™

Defining the therapeutic algorithm in patients with HR positive breast cancer - Germany

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

Oncology

CREDITS

0.50 AMA PRA Category 1 Credit(s)™

Antibody Drug Conjugates (ADC) - Germany

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

Oncology

CREDITS

0.50 AMA PRA Category 1 Credit(s)™

Defining the therapeutic algorithm in patients with HR positive breast cancer - Italy

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

Oncology

CREDITS

0.50 AMA PRA Category 1 Credit(s)™

Defining the therapeutic algorithm in patients with HR positive breast cancer - Japan

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

Oncology

CREDITS

0.50 AMA PRA Category 1 Credit(s)™

Defining the therapeutic algorithm in patients with HR positive breast cancer - Spain

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

Oncology

CREDITS

0.50 AMA PRA Category 1 Credit(s)™

Antibody Drug Conjugates (ADC) - Italy

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

Oncology

CREDITS

0.50 AMA PRA Category 1 Credit(s)™

Antibody Drug Conjugates (ADC) - Japan

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

Oncology

CREDITS

0.50 AMA PRA Category 1 Credit(s)™

Antibody Drug Conjugates (ADC) - Spain

LAUNCH DATE: 13-Sep-2024

EXPIRATION DATE: 13-Sep-2025

Oncology

CREDITS

0.50 AMA PRA Category 1 Credit(s)™